Developmental and reproductive safety evaluation of AV7909 anthrax vaccine candidate in rats.


Journal

Birth defects research
ISSN: 2472-1727
Titre abrégé: Birth Defects Res
Pays: United States
ID NLM: 101701004

Informations de publication

Date de publication:
01 01 2021
Historique:
received: 05 06 2020
revised: 21 07 2020
accepted: 17 09 2020
pubmed: 18 10 2020
medline: 19 8 2021
entrez: 17 10 2020
Statut: ppublish

Résumé

The AV7909 vaccine, consists of the Anthrax Vaccine Adsorbed (AVA) bulk drug substance and the immunostimulatory Toll-like receptor 9 agonist oligodeoxynucleotide adjuvant CPG 7909. The purpose of this research was to evaluate the potential maternal, reproductive, and developmental toxicity of AV7909 in rats to support licensure for use in women of childbearing potential. Groups of first generation (F

Identifiants

pubmed: 33067910
doi: 10.1002/bdr2.1815
pmc: PMC7821328
doi:

Substances chimiques

Anthrax Vaccines 0
Antibodies, Neutralizing 0

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

32-42

Subventions

Organisme : Department of Health and Human Services, Biomedical Advanced Research and Development Authority
ID : HHSO100201600030C

Informations de copyright

© 2020 The Authors. Birth Defects Research published by Wiley Periodicals LLC.

Références

J Morphol. 1969 Mar;127(3):291-305
pubmed: 4388962
Antisense Nucleic Acid Drug Dev. 2001 Oct;11(5):333-40
pubmed: 11763350
MMWR Recomm Rep. 2010 Jul 23;59(RR-6):1-30
pubmed: 20651644
Teratology. 2002 Aug;66(2):77-84
pubmed: 12210011
Vaccine. 2014 Nov 28;32(50):6847-54
pubmed: 24530403
Vaccine. 2013 Jun 26;31(30):3051-8
pubmed: 23701746
Int J Toxicol. 2019 May/Jun;38(3):163-172
pubmed: 31179828
Vaccine. 2017 Aug 3;35(34):4414-4420
pubmed: 28673484
Birth Defects Res B Dev Reprod Toxicol. 2009 Oct;86(5):370-6
pubmed: 19718687
Vaccine. 2017 Sep 5;35(37):4952-4959
pubmed: 28774566
Comp Med. 2009 Dec;59(6):517-26
pubmed: 20034426
Clin Vaccine Immunol. 2013 Jul;20(7):1016-26
pubmed: 23658392
Vaccine. 2011 Aug 26;29(37):6313-20
pubmed: 21624418
Stat Med. 1991 Jun;10(6):939-47
pubmed: 1876783
Teratog Carcinog Mutagen. 1984;4(2):181-8
pubmed: 6145223
Birth Defects Res. 2021 Jan 1;113(1):32-42
pubmed: 33067910
Reprod Toxicol. 2015 Jan;51:90-105
pubmed: 25530039
Birth Defects Res B Dev Reprod Toxicol. 2009 Aug;86(4):227-327
pubmed: 19708059
J Immunol Methods. 2008 Apr 20;333(1-2):89-106
pubmed: 18304568
Vaccine. 2016 Apr 19;34(18):2096-105
pubmed: 26979136

Auteurs

Eve Mylchreest (E)

Battelle, West Jefferson, Ohio, USA.

M Autumn Smiley (MA)

Battelle, West Jefferson, Ohio, USA.

Jeff D Ballin (JD)

Battelle, Aberdeen, Maryland, USA.

Bruna Blauth (B)

Emergent BioSolutions Inc., Gaithersburg, Maryland, USA.

Jeffry Shearer (J)

Emergent BioSolutions Inc., Gaithersburg, Maryland, USA.

Joshua Reece (J)

Emergent BioSolutions Inc., Gaithersburg, Maryland, USA.

Boris Ionin (B)

Emergent BioSolutions Inc., Gaithersburg, Maryland, USA.

Vladimir Savransky (V)

Emergent BioSolutions Inc., Gaithersburg, Maryland, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH